BOS engages structural-cell circuits largely shared with RAS and fibrotic lung diseases, but along an airway-centered rather than parenchyma-centered axis, and shared structural programs may therefore be targetable across CLAD phenotypes.
Jannik Ruwisch, Hande Yilmaz, Leonard Christian et al.· bioRxiv· 0 citations
A potential involvement of vascular remodelling in CLAD pathophysiology is suggested, with changes consistent with pro-inflammatory and fibrogenic processes in CD31+ regions.
Axelle Coppens, Rahel Bodenmann, Janik Riese et al.· American Journal of Transpla...· 1 citation
Insights from experimental models of pulmonary fibrosis and translational research have significantly advanced understanding of these processes and are reviewed in this article, together with current therapeutic advances and future directions.
Nazanin Nazemi, B. Crestani, D. Helou et al.· European Respiratory Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.